Minrui He

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center

发表论文 7 篇 · 总被引 18 次 · h-index 3

代表论文

Hepatic arterial infusion chemotherapy plus targeted therapy and immunotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a retrospective cohort study (2024 · International Journal of Surgery · 被引 9)
Comparing PD ‐ L1 and PD ‐1 inhibitors plus bevacizumab combined with hepatic arterial interventional therapies in unresetable hepatocellular carcinoma: A single‐center, real‐world study (2025 · International Journal of Cancer · 被引 3)
Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy (2023 · Journal of Hepatocellular Carcinoma · 被引 3)
Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy (2023 · Journal of Hepatocellular Carcinoma · 被引 2)
Hepatic arterial infusion chemotherapy combined with donafenib and tislelizumab versus transcatheter chemoembolization alone for hepatocellular carcinoma: A propensity score matching study. (2025 · Journal of Clinical Oncology · 被引 1)
Tescalcin is a phagocytic checkpoint driving immune escape and limiting immunotherapeutic efficacy in hepatocellular carcinoma (2026 · Journal of Clinical Investigation)